切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2020, Vol. 08 ›› Issue (02) : 141 -144. doi: 10.3877/cma.j.issn.2095-5782.2020.02.008

所属专题: 文献

肿瘤介入

局限性人工腹水在临近胃肠管肝肿瘤消融中的应用
李勇1, 郭坚溪1, 孔健1, 沈新颖1,(), 张彦舫1,()   
  1. 1. 518020 广东深圳,深圳市人民医院介入科、暨南大学第二临床医学院、南方科技大学第一附属医院
  • 收稿日期:2020-02-21 出版日期:2020-05-25
  • 通信作者: 沈新颖, 张彦舫
  • 基金资助:
    广东省医学科学技术研究基金项目(B2018131)

Clinical application of local artificial ascites in microwave ablation of liver tumor adjacent to gastrointestinal tracts

Yong Li1, Jianxi Guo1, Jian Kong1, Xinying Shen1,(), Yanfang Zhang1,()   

  1. 1. Department of Interventional Radiology, Shenzhen People's Hospital, the Second Clinical Medical College of Jinan University, the First Affiliated Hospital of South University of Science and Technology, Guangdong Shenzhen 518020, China
  • Received:2020-02-21 Published:2020-05-25
  • Corresponding author: Xinying Shen, Yanfang Zhang
  • About author:
    Corresponding authors: Shen Xinying, Email: ;
    Zhang Yanfang, Email:
引用本文:

李勇, 郭坚溪, 孔健, 沈新颖, 张彦舫. 局限性人工腹水在临近胃肠管肝肿瘤消融中的应用[J/OL]. 中华介入放射学电子杂志, 2020, 08(02): 141-144.

Yong Li, Jianxi Guo, Jian Kong, Xinying Shen, Yanfang Zhang. Clinical application of local artificial ascites in microwave ablation of liver tumor adjacent to gastrointestinal tracts[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2020, 08(02): 141-144.

目的

探讨CT引导下局限性人工腹水辅助在经皮微波消融治疗临近肠管肝肿瘤的有效性和安全性。

方法

我院2015年至2019年中对48例临近肠管肝肿瘤病灶行CT引导下人工腹水辅助下微波消融术。对局限性人工腹水技术成功率、微波消融局部复发率、手术并发症等进行评估。

结果

48例患者中47例成功行局限性人工腹水,28例患者之前有外科手术史,1例因局部粘连未能成功行局限人工腹水。47例患者均成功行微波消融术,1例术后腹腔少量出血,术后1月复查均完全消融。

结论

局限性人工腹水辅助微波消融治疗临近胃肠道肝肿瘤病灶是一种安全、有效的治疗方法。

Objective

To investigate the efficacy and safety of CT guided local artificial ascites assisted percutaneous microwave ablation in the treatment of liver tumors adjacent to the intestinal tract.

Methods

From 2015 to 2019 in our hospital, 48 cases of liver tumor adjacent to intestinal tract were treated by CT guided artificial ascites assisted microwave ablation. The success rate of local artificial ascites, local recurrence rate of microwave ablation and complications of operation were evaluated.

Results

Among the 48 patients, 47 patients were succeeded in local artificial ascites, 28 patients had a history of surgery before, and 1 patient failed because of local adhesion. 47 patients were successfully treated with microwave ablation, 1 patient suffered from a small amount of bleeding in abdominal cavity, and all of them were completely ablated one month after operation.

Conclusions

Local artificial ascites assisted with microwave ablation isa safe and effective treatment for liver tumor near gastrointestinal tract.

图1 患者,男,51岁。1A:S3段小肝癌;1B:行介入治疗注入碘化油标记,肿瘤与胃窦贴近;1C:21 G细针穿刺入肝胃间隙,注入生理盐水,造成人工腹水;1D:注入400 ml生理盐水后,局限性人工腹水效果满意;1E:微波针穿刺病灶开始消融;1F:术后1个月,复查CT,肿瘤消融完全,效果满意。
[1]
Kamal A, Elmoety AA, Rostom Y, et al. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial[J].Gastrointest Oncol, 2019, 10(3): 562-571.
[2]
Poggi G, Tosoratin N, Montagna B, et al. Microwave ablation of hepato-cellularcarcinoma[J]. World Journal of Hepatology, 2015, 7(25): 88-89.
[3]
Francica G, Maloni, MF, Dasiol, et al. Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy[J]. Eurpean Journal of Radiology, 2016, 85(4): 739-743.
[4]
Hsieh YC, Limquiaco JL, Lin CC, et al. Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations[J]. Abdom Radiol (NY), 2019, 44(3): 1141-1151.
[5]
Hayashida K, Ooi J, Makiyama K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma in hepatic dome directly under right diaphragm-the trial of artificial ascites method[J]. Nihon Shokakibyo Gakkai Zasshi, 1995, 92(10):1752-1758.
[6]
Nishimura M, Nouso K, Kariyama K, et al. Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma[J]. Acta Med Okayama, 2012, 66(3): 279-284.
[7]
乔强,李海莹,吴佳恒,等.人工腹水下射频消融和微波消融治疗毗邻重要器官的肝癌[J].中国微创外科杂志,2016, 16(8): 724-727.
[8]
李凯,王平,郑荣琴,等.超声引导下人工腹水辅助肝癌微波消融治疗研究[J].中华医学超声杂志(电子版),2010, 7(10): 1685-1690.
[9]
Asvadi NH, Anvari A, Uppot RN, et al. CT-guided percutaneous microwave ablation of tumors in the hepatic dome: assessment of efficacy and safety[J]. J Vasc Interv Radiol, 2016, 27(4): 496-502.
[10]
Wang CC, Kao JH. Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma[J]. Hepatol Int, 2015, 9(4): 514-519.
[11]
黄倩楠,许尔蛟,曾庆劲,等.人工腹水辅助热消融有腹腔手术史患者邻近胃肠道肝肿瘤的应用价值[J].中华超声影像学杂志,2016, 25(1): 36-39.
[12]
张明军,李季,陈振东,等.人工注射局部水囊技术辅助超声引导射频消融治疗高危部位肝肿瘤的临床研究[J].肝胆外科杂志,2013, 21(6): 418-420.
[13]
周进学,展翔宇,李庆军,等.人工腹水辅助超声引导邻近胃肠道肝脏肿瘤射频消融术[J].中华肝胆外科杂志,2018, 24(1): 9-12.
[14]
Hakime A, Tselikasl L, Otmezguine Y, et al. Artificial ascites for pain relief during microwave ablation of subcapsular liver tumors[J]. Cardiovasc Intervent Radiol, 2015, 38(6): 1557-1562.
[15]
Zhang M, Liang P, Cheng ZG, et al. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumors adjacent to the gastrointestinal tract[J]. Int J Hyperth, 2014, 30(2): 134-141.
[16]
Liu SR, Liang P, Yu XL, et al. Percutaneous microwave ablation for liver tumours adjacent to the marginal angle[J]. Int J Hyperthermia, 2014, 30(5): 306-311.
[17]
Jin T, Liu X, Dai C, et al. Beneficial impact of microwave ablation assisted laparoscopic hepatectomy in cirrhotic hepatocellular carcinoma patients: a propensity score matching analysis[J]. Int J Hyperthermia, 2019, 36(1): 530-537.
[18]
Lao OB, Farjah F, Flum DR, et al. Adverse events after radiofrequency ablation of unresectable liver tumors: a single center experience[J]. Am J Surg, 2009, 198(1): 76-82.
[1] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[2] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[4] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[5] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[6] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[7] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[8] 林小勇, 张兰霞, 曾庆劲, 贺需旗, 谭雷, 郭光辉, 龙颖琳, 李凯, 吴宇轩. 负压抽吸活检针在肝困难病灶活检中的初步应用研究[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 694-698.
[9] 雷永琪, 刘新阳, 杨黎渝, 铁学宏, 俞星新, 耿志达, 刘雨, 陈政良, 惠鹏, 梁英健. 肝脏血管周上皮样细胞肿瘤合并贫血一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 710-718.
[10] 欧阳佳裕, 李刚, 贺露瑶, 罗娜. 双层探测器光谱CT在早期原发性肝癌中的诊断价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 557-561.
[11] 陈志坚, 俞建达, 池小斌, 吕立志, 陈永标. 三维可视化技术在腹腔镜肝巨大肿瘤切除中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 302-307.
[12] 黄俊豪, 陈宗杰, 胡添松. 血小板相关参数对肝内胆管细胞癌根治性切除患者预后预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 308-312.
[13] 马欢欢, 马晨辉, 邓小博, 王博方, 何普毅, 王云鹏, 许博, 俞荣, 王娜, 陈昊. 肝癌实体瘤治疗疗效评价系统的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 377-383.
[14] 王凯飞, 牟怡平, 李晓辉, 王瑞涛, 侯惠莲, 张月浪. 原发性肝平滑肌肉瘤临床病理特征及疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 357-362.
[15] 韦巧玲, 黄妍, 赵昌, 宋庆峰, 陈祖毅, 黄莹, 蒙嫦, 黄靖. 肝癌微波消融术后中重度疼痛风险预测列线图模型构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 715-721.
阅读次数
全文


摘要